Tag: bioequivalence

Do Generic Drugs Have Different Interaction Risks Than Brand Names?

By : Tamsin Riverton
Date : Apr 10 2026

Discover if generic medications carry different drug interaction risks than brand-name drugs. Learn about bioequivalence, inactive ingredients, and safety data.

Quality by Design (QbD) in Generic Drug Development: Modern Science-Based Approaches

By : Tamsin Riverton
Date : Apr 5 2026

Explore how Quality by Design (QbD) transforms generic drug development from a 'copycat' method to a science-driven process that accelerates FDA ANDA approvals.

Perception vs Reality: Why Generics Seem Less Effective Than Brand-Name Drugs

By : Tamsin Riverton
Date : Feb 24 2026

Generics are scientifically identical to brand-name drugs, yet many people believe they’re less effective. This article explains why the perception gap exists, how it affects health outcomes, and what you can do about it.

Bioequivalence Explained: FDA Requirements to Prove Generic Drug Equivalence

By : Tamsin Riverton
Date : Feb 17 2026

Bioequivalence is the scientific standard the FDA uses to ensure generic drugs work the same as brand-name versions. It's not about price - it's about how your body absorbs the medicine. Here's how it works.

Pharmacokinetic Studies and Generic Drug Equivalence: What You Really Need to Know

By : Tamsin Riverton
Date : Feb 4 2026

Pharmacokinetic studies are commonly called the 'gold standard' for proving generic drugs work the same as brand-name versions. But the reality is more complex. This article explains how these studies actually work, their limitations for certain drugs, and why regulators use multiple testing methods to ensure safety and effectiveness.